1.
|
Scherl-Mostageer M, Sommergruber W,
Abseher R, Hauptmann R, Ambros P and Schweifer N: Identification of
a novel gene, CDCP1, overexpressed in human colorectal cancer.
Oncogene. 20:4402–4408. 2001. View Article : Google Scholar : PubMed/NCBI
|
2.
|
Bhatt AS, Erdjument-Bromage H, Tempst P,
Craik CS and Moasser MM: Adhesion signaling by a novel mitotic
substrate of src kinases. Oncogene. 24:5333–5343. 2005. View Article : Google Scholar : PubMed/NCBI
|
3.
|
Uekita T, Tanaka M, Takigahira M, Miyazawa
Y, Nakanishi Y, Kanai Y, Yanagihara K and Sakai R:
CUB-domain-containing protein 1 regulates peritoneal dissemination
of gastric scirrhous carcinoma. Am J Pathol. 172:1729–1739. 2008.
View Article : Google Scholar : PubMed/NCBI
|
4.
|
Ikeda JI, Morii E, Kimura H, Tomita Y,
Takakuwa T, Hasegawa JI, Kim YK, Miyoshi Y, Noguchi S, Nishida T
and Aozasa K: Epigenetic regulation of the expression of the novel
stem cell marker CDCP1 in cancer cells. J Pathol. 210:75–84. 2006.
View Article : Google Scholar : PubMed/NCBI
|
5.
|
Bühring HJ, Kuçi S, Conze T, Rathke G,
Bartolović K, Grünebach F, Scherl-Mostageer M, Brümmendorf TH,
Schweifer N and Lammers R: CDCP1 identifies a broad spectrum of
normal and malignant stem/progenitor cell subsets of hematopoietic
and nonhematopoietic origin. Stem Cells. 22:334–343.
2004.PubMed/NCBI
|
6.
|
Dorshkind K: Regulation of hematopoiesis
by bone marrow stromal cells and their products. Annu Rev Immunol.
8:111–137. 1990. View Article : Google Scholar
|
7.
|
Baines P, Mayani H, Bains M, Fisher J, Hoy
T and Jacobs A: Enrichment of CD34 (My10)-positive myeloid and
erythroid progenitors from human marrow and their growth in
cultures supplemented with recombinant human granulocyte-macrophage
colony-stimulating factor. Exp Hematol. 16:785–978. 1988.
|
8.
|
Gartner S and Kaplan HS: Long-term culture
of human bone marrow cells. Proc Natl Acad Sci USA. 77:4756–4759.
1980. View Article : Google Scholar : PubMed/NCBI
|
9.
|
Larochelle A, Vormoor J, Hanenberg H, Wang
JC, Bhatia M, Lapidot T, Moritz T, Murdoch B, Xiao XL, Kato I,
Williams DA and Dick JE: Identification of primitive human
hematopoietic cells capable of repopulating NOD/SCID mouse bone
marrow: implications for gene therapy. Nat Med. 2:1329–1337. 1996.
View Article : Google Scholar : PubMed/NCBI
|
10.
|
Bhatia M, Wang JC, Kapp U, Bonnet D and
Dick JE: Purification of primitive human hematopoietic cells
capable of repopulating immune-deficient mice. Proc Natl Acad Sci
USA. 94:5320–5325. 1997. View Article : Google Scholar : PubMed/NCBI
|
11.
|
De Wynter EA, Buck D, Hart C, Heywood R,
Coutinho LH, Clayton A, Rafferty JA, Burt D, Guenechea G, Bueren
JA, Gagen D, Fairbairn LJ, Lord BI and Testa NG:
CD34+AC133+ cells isolated from cord blood
are highly enriched in long-term culture-initiating cells,
NOD/SCID-repopulating cells and dendritic cell progenitors. Stem
Cells. 16:387–396. 1998.
|
12.
|
Conze T, Lammers R, Kuci S,
Scherl-Mostageer M, Schweifer N, Kanz L and Buhring HJ: CDCP1 is a
novel marker for hematopoietic stem cells. Ann NY Acad Sci.
996:222–226. 2003. View Article : Google Scholar : PubMed/NCBI
|
13.
|
Hara H, Kai S, Fushimi M, Taniwaki S,
Okamoto T, Ohe Y, Fujita S, Noguchi K, Senba M, Hamano T, Kanamaru
A and Nagai K: Pluripotent hemopoietic precursors in vitro
(CFU-MIX) in aplastic anemia. Exp Hematol. 8:1165–1171. 1980.
|
14.
|
Fujimori Y, Hara H and Nagai K: Effect of
lymphokine-activated killer cell fraction on the development of
human hematopoietic progenitor cells. Cancer Res. 48:534–538.
1988.PubMed/NCBI
|
15.
|
Fujimori Y, Ogawa M, Clark SC and Dover
GJ: Serum-free culture of enriched hematopoietic progenitors
reflects physiologic levels of fetal hemoglobin biosynthesis.
Blood. 75:1718–1722. 1990.
|
16.
|
Nishioka K, Fujimori Y, Hashimoto-Tamaoki
T, Kai S, Qiu H, Kobayashi N, Tanaka N, Westerman KA, Leboulch P
and Hara H: Immortalization of bone marrow-derived human
mesenchymal stem cells by removable simian virus 40T antigen gene:
Analysis of the ability to support expansion of cord blood
hematopoietic progenitor cells. Int J Oncol. 23:925–932. 2003.
|
17.
|
Yoshino H, Ueda T, Kawahata M, Kobayashi
K, Ebihara Y, Manabe A, Tanaka R, Ito M, Asano S, Nakahata T and
Tsuji K: Natural killer cell depletion by anti-asialo GM1 antiserum
treatment enhances human hematopoietic stem cell engraftment in
NOD/Shi-scid mice. Bone Marrow Transplant. 26:1211–1216. 2000.
View Article : Google Scholar : PubMed/NCBI
|
18.
|
Qiu H, Fujimori Y, Kai S, Fujibayashi Y,
Nishioka K and Hara H: Establishment of mouse embryonic fibroblast
cell lines that promote ex vivo expansion of human cord blood
CD34+ hematopoietic progenitors. J Hematother Stem Cell
Res. 12:39–46. 2003. View Article : Google Scholar : PubMed/NCBI
|
19.
|
Becker M, Nitsche A, Neumann C, Aumann J,
Junghahn I and Fichtner I: Sensitive PCR method for the detection
and real-time quantification of human cells in xenotransplantation
systems. Br J Cancer. 87:1328–1335. 2002. View Article : Google Scholar : PubMed/NCBI
|
20.
|
Bhatia M, Bonnet D, Murdoch B, Gan OI and
Dick JE: A newly discovered class of human hematopoietic cells with
SCID-repopulating activity. Nat Med. 4:1038–1045. 1998. View Article : Google Scholar : PubMed/NCBI
|
21.
|
Wong CH, Baehner FL, Spassov DS, Ahuja D,
Wang D, Hann B, Blair J, Shokat K, Welm AL and Moasser MM:
Phosphorylation of the SRC epithelial substrate Trask is tightly
regulated in normal epithelia but widespread in many human
epithelial cancers. Clin Cancer Res. 15:2311–2322. 2009. View Article : Google Scholar : PubMed/NCBI
|
22.
|
Spassov DS, Baehner FL, Wong CH, McDonough
S and Moasser MM: The transmembrane src substrate Trask is an
epithelial protein that signals during anchorage deprivation. Am J
Pathol. 174:1756–1765. 2009. View Article : Google Scholar : PubMed/NCBI
|
23.
|
Rane SG and Reddy EP: JAKs, STATs and Src
kinases in hematopoiesis. Oncogene. 21:3334–3358. 2002. View Article : Google Scholar : PubMed/NCBI
|